Total Payments
$549.76
2024 Payments
$102.94
Companies
13
Transactions
26
Medicare Patients
2,184
Medicare Billing
$478,706
Payment Breakdown by Category
Food & Beverage$549.76 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $549.76 | 26 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $125.44 | 5 | $0 (2021) |
| Medtronic Vascular, Inc. | $103.36 | 1 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $60.88 | 4 | $0 (2017) |
| Amgen Inc. | $59.65 | 4 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $44.60 | 3 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $26.73 | 2 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $26.73 | 1 | $0 (2019) |
| Collegium Pharmaceutical, Inc. | $19.74 | 1 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $19.60 | 1 | $0 (2024) |
| Corcept Therapeutics | $19.35 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $102.94 | 6 | Amgen Inc. ($44.25) |
| 2023 | $28.92 | 2 | SANOFI PASTEUR INC. ($15.03) |
| 2021 | $72.55 | 5 | PFIZER INC. ($32.96) |
| 2020 | $13.77 | 1 | PFIZER INC. ($13.77) |
| 2019 | $130.09 | 2 | Medtronic Vascular, Inc. ($103.36) |
| 2018 | $29.98 | 2 | Janssen Pharmaceuticals, Inc ($17.85) |
| 2017 | $171.51 | 8 | PFIZER INC. ($78.71) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $19.74 | General |
| Category: Opioid Analgesic | ||||||
| 10/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Inflammation | ||||||
| 10/17/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Cardiology | ||||||
| 09/03/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Endocrinology | ||||||
| 05/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Inflammation | ||||||
| 03/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Inflammation | ||||||
| 08/08/2023 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE, FLUZONE QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Vaccines | ||||||
| 06/02/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/08/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/04/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/23/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/11/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/20/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/05/2019 | Medtronic Vascular, Inc. | ClosureRFS (Device) | Food and Beverage | In-kind items and services | $103.36 | General |
| Category: EndoVenous Therapies | ||||||
| 03/07/2019 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/04/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: DIABETES | ||||||
| 12/12/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Urology | ||||||
| 11/02/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $51.01 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/10/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: DIABETES | ||||||
| 07/11/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: DIABETES | ||||||
| 05/04/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/13/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Endocrinology | ||||||
| 04/11/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 331 | 1,660 | $204,514 | $142,899 |
| 2022 | 6 | 441 | 1,617 | $168,682 | $99,552 |
| 2021 | 9 | 630 | 1,949 | $189,181 | $115,017 |
| 2020 | 14 | 782 | 2,428 | $195,041 | $121,238 |
Total Patients
2,184
Total Services
7,654
Medicare Billing
$478,706
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 70 | 720 | $75,717 | $55,447 | 73.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 385 | $48,125 | $34,105 | 70.9% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 45 | 247 | $37,050 | $29,220 | 78.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 153 | $30,600 | $16,518 | 54.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 51 | 132 | $10,589 | $6,062 | 57.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 11 | 11 | $1,833 | $1,471 | 80.2% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 11 | 12 | $600.00 | $76.51 | 12.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 96 | 377 | $46,026 | $29,895 | 65.0% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 90 | 416 | $28,296 | $20,449 | 72.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 66 | 156 | $30,878 | $18,476 | 59.8% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 66 | 226 | $38,480 | $15,335 | 39.9% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 100 | 417 | $20,877 | $12,312 | 59.0% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 23 | 25 | $4,125 | $3,086 | 74.8% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 138 | 659 | $59,415 | $33,283 | 56.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 104 | 290 | $43,464 | $24,845 | 57.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 76 | 166 | $29,155 | $20,963 | 71.9% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2021 | 145 | 620 | $31,000 | $19,621 | 63.3% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 52 | 53 | $6,906 | $4,879 | 70.6% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 33 | 37 | $6,140 | $4,849 | 79.0% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 45 | 71 | $8,490 | $4,504 | 53.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 35 | $3,171 | $1,105 | 34.9% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2021 | 17 | 18 | $1,440 | $968.97 | 67.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 138 | 559 | $69,744 | $37,717 | 54.1% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2020 | 167 | 922 | $46,247 | $30,647 | 66.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 146 | 521 | $43,280 | $27,879 | 64.4% |
About Dr. Robert Han, MD
Dr. Robert Han, MD is a Specialist healthcare provider based in Iron River, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003859406.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Han, MD has received a total of $549.76 in payments from pharmaceutical and medical device companies, with $102.94 received in 2024. These payments were reported across 26 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($549.76).
As a Medicare-enrolled provider, Han has provided services to 2,184 Medicare beneficiaries, totaling 7,654 services with total Medicare billing of $478,706. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Iron River, MI
- Active Since 06/14/2006
- Last Updated 08/15/2018
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1003859406
Products in Payments
- ELIQUIS (Drug) $125.44
- ClosureRFS (Device) $103.36
- SOLIQUA (Drug) $50.32
- XARELTO (Drug) $44.60
- Otezla (Drug) $44.25
- BROVANA (Drug) $26.73
- FARXIGA (Drug) $26.73
- Belbuca (Drug) $19.74
- OPSUMIT (Drug) $19.60
- Korlym (Drug) $19.35
- Myrbetriq (Drug) $16.52
- Prolia (Biological) $15.40
- FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) $15.03
- JARDIANCE (Drug) $12.13
- TOUJEO (Drug) $10.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.